Uric Acid as a Prognostic Factor for Survival Time: A Prospective Cohort Study of Terminally Ill Cancer Patients

Journal of Pain and Symptom Management

Volumn 31, Issue 6, 2006, Pages 493-501

  Shin, Hyun Sik ^a   Lee, Hye Ree ^a   Lee, Duk Chul ^a   Shim, Jae Yong ^a   Cho, Kyung Hee ^a   Suh, Sang Yeon ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

prognostic factor; survival; terminal cancer; Uric acid

Indexed keywords

CHOLESTEROL; LACTATE DEHYDROGENASE; URIC ACID;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PAIN; CANCER PATIENT; CANCER SURVIVAL; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; HAZARD ASSESSMENT; HUMAN; HYPOCHOLESTEROLEMIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; PARSIMONY ANALYSIS; PREDICTION; PROTHROMBIN TIME; SAMPLE SIZE; SURVIVAL RATE; SURVIVAL TIME; TERMINAL DISEASE; TERMINALLY ILL PATIENT; URIC ACID BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE; TERMINALLY ILL; URIC ACID;

EID: 33745462928     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2005.11.014     Document Type: Article

References (25)

1. Christakis N.A. Death foretold: prophecy and prognosis in medical care (2000), University of Chicago, Chicago
2. Yoon Y.H., Huh D.S., Bae J.M., et al. Retrospective cohort study for prognostic fastors in the terminally ill cancer patient. J Korean Cancer Assoc 30 2 (1998) 384-393
3. Yeom C.H., Choi Y.S., Lee H.R., Hong Y.S., and Park Y.K. Estimation of survival by clinical factors in terminally ill cancer patients. J Korean Soc Hospice Palliat Care 1 2 (2000) 30-38
4. Wanzer S.H., and Aldestein S.J. The physician's responsibility toward hopelessly ill patients. N Engl J Med 310 (1984) 955-959
5. Pearlman R.A. Inaccurate predictions of life expectancy: dilemmas and opportunities. Arch Intern Med 148 (1988) 2537-2538
6. Evans C., and McCarthy M. Prognostic uncertainty in terminal care: can the Karnofsky index help?. Lancet 1 (1985) 1204-1206
7. Forster L.E., and Lynn J. Predicting life span for applicants to inpatient hospice. Arch Intern Med 148 (1988) 2540-2543
8. Chuang R.-B., and Hu W.-Y. Prediction of survival in terminal cancer patients in Taiwan: constructing a prognostic scale. J Pain Symptom Manage 28 (2004) 115-122
9. Lamont E.B., and Christakis N.A. Complexities in prognostication in advanced cancer. JAMA 290 (2003) 98-104
10. Pirovano M., Maltoni M., and Nanni O. A new palliative prognostic score: a first step for the staging of terminal ill cancer patients. J Pain Symptom Manage 17 (1999) 231-239
11. Maltoni M., Pirovano M., Nanni O., et al. Biological indices predictive of survival in 519 Italian terminally ill cancer patient. J Pain Symptom Manage 13 (1997) 1-9
12. Lee D.H., Kim S.H., Choi Y.S., et al. Impacts of performance status, clinical symptom and laboratory findings on survival in patients with advanced cancer. J Korean Acad Family Med 22 (2001) 1794-1805
13. Bozcuk H., Koyuncu E., Yildiz M., et al. A simple and accurate prediction model to estimate the intrahospital mortality risk of hospitalised cancer patients. Int J Clin Pract 58 (2004) 1014-1019
14. Antonio V., Nora D., Irene J., et al. Quality of life and survival prediction in terminal cancer patients. Cancer 101 (2004) 1090-1098
15. Rosenthal M.A., Gegski V.J., Kefford R.F., and Stuart-Harris R.C. Prediction of life-expectancy in hospice patients: identification of novel prognostic factors. Palliat Med 7 (1993) 199-204
16. Leo K.N., David E.L., Kristiina N., et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men. Arch Intern Med 164 (2004) 1546-1551
17. Levine W., Dyer A.R., Shekelle R.B., Schoenberger J.A., and Stamler J. Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol 42 (1989) 257-267
18. Tomita M., Mizuno S., and Yamanaka H. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol 10 6 (2000) 403-409
19. Mazza A., and Casiglia E. Predictors of cancer mortality in elderly subjects. Eur J Epidemiol 15 5 (1999) 421-427
20. Robert L.W. Disorders of purine and pyrimidine metabolism. Harrison's principles of internal medicine. 16th ed. (2005), McGraw-Hill, New York pp. 2308-2313
21. Shi Y. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 1991 (2003)
22. Woolliscroft J.O., Colfer H., and Fox I.H. Hyperuricemia in acute illness: a poor prognostic sign. Am J Med 72 1 (1982) 58-62
23. Iseki K., Oshiro S., and Tozawa M. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 24 6 (2001) 691-697
24. Peter W., and Lutgarde T. Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur Trial. J Am Soc Nephrol 13 (2002) 2213-2222
25. Alexander K., Patrick M.S., James L.J., and Kent B.L. Appendices: Laboratory values of clinical importance. Harrison's principles of internal medicine. 16th ed. (2005), McGraw-Hill, New York A1-9